美常安联合六味安消治疗慢性功能性便秘的疗效观察

The Therapeutic Effects of Medilac-S with Liuwei-Anxiao on Chronic Functional Constipation

目的评价美常安联合六味安消治疗慢性功能性便秘的疗效。方法慢性功能性便秘患者89例,采用平行、双盲、随机的方法分为三组,A组(n=31)口服美常安+六味安消,B组(n=30)口服美常安,C组(n=28)口服六味安消,治疗疗程为4周。结果治疗4周后,三组总缓解率分别为96.77%,53.33%,57.14%,A组显著高于B和C两组(P<0.05)。结论美常安联合六味安消治疗慢性功能性便秘优于单用一种药物,且效果明显,安全有效,值得临床推广应用。

Objective To evaluate abstract the therapeutic effects of Medilac-S combined with Liuwei-Anxiao on chronic functional constipation. Methods 89 patients with chronic functional constipation were randomly divided into 3 groups： Medilac-S plus Liuwei-Anxiao group（A,n=31）,Medilac-S group（B,n=30）, Liuwei-Anxiao group（C,n=28）,the treatment lasted for 4 weeks.Results After 4 weeks of treatment, the total remission rates were 96.77%, 53.33%, 57.14% respectively in group A, B and C, A group was significantly higher than that of B and C groups （P＆lt;0.05）.Conclusion Combined use of Medilac-S with Liuwei-Anxiao on chronic functional constipation is better than one drug alone, and the results are obvious, safe,and effective, worthy of clinical application.